Enhanced communication and seamless data sharing capabilities augment clinical and operational efficiencies for patient assessment across emergency care settings “First responders don’t often know ...
Amsterdam, the Netherlands and Cambridge, MA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of ...
The therapy delivered by the HeartStart FR2+ is the most proven in the industry. More than 40 studies confirm its effectiveness. Philips’ high-current/low energy therapy ensures a potent ...
Philips HeartStart OnSite AEDs help allow anyone with little or no training to treat the most common cause of suspected sudden cardiac arrest (SCA) by delivering a shock quickly and effectively, ...
Philips receives FDA premarket approval for its HeartStart OnSite and HeartStart Home defibrillators
Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of the Food and Drug ...
Federal health regulators in the U.S. are warning the public that certain cardiac defibrillators recalled by Philips Healthcare may fail to deliver a needed shock in an emergency. Defibrillators are ...
The U.S. Food and Drug Administration has issued a safety communication saying certain HeartStart automated external defibrillator devices made by Philips Medical Systems, a division of Philips ...
The US Food and Drug Administration (FDA) is classifying a recent safety notice covering certain models of the HeartStart MRx Monitor/Defibrillator due to electrical and battery connection issues as a ...
The Food and Drug Administration (FDA) is warning consumers that some models of HeartStart automated external defibrillators (AED) may not work during a cardiac emergency. The devices, which are made ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results